Salud financiera de hoja de balance de Xintec

Salud financiera controles de criterios 6/6

Xintec tiene un patrimonio de accionistas total de NT$8.0B y una deuda total de NT$0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son NT$10.0B y NT$2.0B respectivamente. El BAIT de Xintec es de NT$1.7B, por lo que su ratio de cobertura de intereses es de -37.7. Tiene efectivo e inversiones a corto plazo que ascienden a NT$3.7B.

Información clave

1.2%

Ratio deuda-patrimonio

NT$102.32m

Deuda

Ratio de cobertura de intereses	-37.9x
Efectivo	NT$4.16b
Patrimonio	NT$8.28b
Total pasivo	NT$2.14b
Activos totales	NT$10.42b

Actualizaciones recientes sobre salud financiera

Is Xintec (GTSM:3374) Using Too Much Debt?

Dec 30

Recent updates

Is It Worth Buying Xintec Inc. (GTSM:3374) For Its 1.5% Dividend Yield?

Apr 16

Xintec (GTSM:3374) Is Achieving High Returns On Its Capital

Mar 29

Xintec Inc.'s (GTSM:3374) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 11

An Intrinsic Calculation For Xintec Inc. (GTSM:3374) Suggests It's 49% Undervalued

Feb 18

The Xintec (GTSM:3374) Share Price Has Soared 412%, Delighting Many Shareholders

Dec 15

Does Xintec's (GTSM:3374) CEO Salary Compare Well With The Performance Of The Company?

Nov 30

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$5.4B) de 3374 superan a sus pasivos a corto plazo (NT$1.5B).

Pasivo a largo plazo: Los activos a corto plazo de 3374 (NT$5.4B) superan a sus pasivos a largo plazo (NT$577.5M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 3374 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de 3374 ha pasado de 75.3% a 1.2% en los últimos 5 años.

Cobertura de la deuda: La deuda de 3374 está bien cubierta por el flujo de caja operativo (1834.5%).

Cobertura de intereses: 3374 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.

Salud financiera de hoja de balance de Xintec

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Is Xintec (GTSM:3374) Using Too Much Debt?

Recent updates

New minor risk - Share price stability

Upcoming dividend of NT$2.00 per share

Investor sentiment improves as stock rises 23%

Dividend of NT$2.00 announced

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Xintec Inc. to Report Q1, 2024 Results on May 09, 2024

Xintec Inc., Annual General Meeting, May 30, 2024

Third quarter 2023 earnings released: EPS: NT$1.89 (vs NT$2.22 in 3Q 2022)

New minor risk - Share price stability

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of NT$3.00 per share at 2.3% yield

Investor sentiment improves as stock rises 22%

Xintec Inc. Appoints Mike Liang as Independent Director

Price target decreased by 7.4% to NT$119

Full year 2022 earnings: EPS exceeds analyst expectations

Xintec Inc. to Report Q4, 2022 Results on Feb 09, 2023

Price target decreased to NT$118

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 22% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Consensus EPS estimates increase by 26%

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$3.00 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to NT$117

Insufficient new directors

Consensus EPS estimates fall by 23%

Full year 2021 earnings: EPS and revenues miss analyst expectations

Xintec Inc., Annual General Meeting, May 26, 2022

Xintec Inc. to Report Q4, 2021 Results on Feb 10, 2022

Insufficient new directors

Insufficient new directors

Investor sentiment improved over the past week

Upcoming dividend of NT$2.50 per share

Investor sentiment deteriorated over the past week

Price target decreased to NT$166

Consensus EPS estimates fall to NT$7.08

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Is It Worth Buying Xintec Inc. (GTSM:3374) For Its 1.5% Dividend Yield?

Consensus EPS estimates fall to NT$8.54

Xintec (GTSM:3374) Is Achieving High Returns On Its Capital

Full year 2020 earnings released: EPS NT$6.37 (vs NT$0.67 in FY 2019)

Xintec Inc.'s (GTSM:3374) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Revenue misses expectations

Xintec Inc., Annual General Meeting, May 27, 2021

Full year 2020 earnings released: EPS NT$6.37 (vs NT$0.67 in FY 2019)

An Intrinsic Calculation For Xintec Inc. (GTSM:3374) Suggests It's 49% Undervalued

This Xintec Inc. (GTSM:3374) Analyst Is Way More Bearish Than They Used To Be

What Is Xintec Inc.'s (GTSM:3374) Share Price Doing?

Here's Why I Think Xintec (GTSM:3374) Is An Interesting Stock

Is Xintec (GTSM:3374) Using Too Much Debt?

Investor sentiment deteriorated over the past week

The Xintec (GTSM:3374) Share Price Has Soared 412%, Delighting Many Shareholders

Market bids up stock over the past week

New 90-day high: NT$199

Does Xintec's (GTSM:3374) CEO Salary Compare Well With The Performance Of The Company?

Third quarter 2020 earnings released: EPS NT$2.21

Third quarter 2020 earnings released: EPS NT$2.20

Market bids up stock over the past week

New 90-day high: NT$135

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera